Navigation Links
The Lancet: New trial suggests cheaper drugs for common heart attack procedure could improve outcomes and save health budgets millions
Date:7/4/2014

A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment. The study suggests that use of one of the drugs, heparin, could result in improved outcomes (such as a reduced rate of repeat heart attacks), compared to the other drug tested, bivalirudin, which is in widespread use in high-income countries, and is around 400 times more expensive than heparin.

The results of the HEAT-PPCI trial suggest that systematic use of heparin rather than bivalirudin after primary percutaneous coronary intervention (PPCI) the most commonly used treatment for heart attack, which unblocks the arteries carrying blood to the heart could save health services substantial sums of money, at the same time as potentially improving patient outcomes.

Patients who undergo PPCI usually receive a combination of antithrombotic drugs to prevent any further blood clots forming during the procedure and after it has been completed. The most commonly used antithrombotic drugs are unfractionated heparin and bivalirudin, and although several previous trials have compared the two drugs, the evidence is unclear as to which drug results in better outcomes.

The trial took place at the Liverpool Heart and Chest Hospital in the UK, where 1829 patients undergoing emergency angiography (an x-ray examination of the heart's arteries after a suspected heart attack) were recruited to the trial. More than four fifths of these patients then went on to receive PPCI; approximately half received heparin, and half received bivalirudin. Researchers then recorded how many patients in both groups experienced a major adverse cardiac event, such as death or another heart attack, within 28 days after surgery.

The results show that overall rates of major adverse cardiac events were significantly lower in the group who received heparin, although the rates of adverse events were low, as expected, in both groups
'/>"/>

Contact: Matthew Back
matthew.back@lhch.nhs.uk
44-015-160-01423
The Lancet
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. The Lancet: Midwifery matters more than ever
2. The Lancet: UK has one of the highest death rates for children in western Europe
3. The Lancet: China halves tuberculosis prevalence in just 20 years
4. First evidence for painless atrial fibrillation treatment
5. ASPIRE Phase III trial of vaginal ring to prevent HIV completes enrollment of 2,629 women
6. GW leads clinical trial to reduce epileptic seizures in people with temporal lobe epilepsy
7. First first patient enrolled in PROSPECT II clinical trial
8. New definition of kidney disease for clinical trials could lead to new treatments
9. Trial uncovers potential dangers of chemotherapy regimen for bladder cancer patients
10. UH part of $7.5M NIH clinical trial on nearsightedness in children
11. Experimental trial represents promising step toward universal antidote for snakebite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 30, 2014 Famous review website ... GoDaddy and GreenGeeks are the most recommended suppliers for ... hosting products (including VPS and cloud hosting) at affordable ... plans. The monthly price for shared hosting plans depends ... a web hosting provider known for its flexible hosting ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 Skmen.com, a famous ... of sexy mini dresses . At the moment, all ... 30 percent off. The deadline of the promotion is September ... worldwide clients with the latest information about our hot designs, ... online store. We hope to help all stylish ladies to ...
(Date:8/29/2014)... August 29, 2014 DailyGossip.org publishes a ... an absolutely unique method of curing multiple sclerosis in ... was created by Dr. Gary M. Levin, who has ... started to become interested in alternative remedies for a ... remedies cannot be effective in all cases for the ...
(Date:8/29/2014)... Chicago (PRWEB) August 29, 2014 Champion ... against muscle disease by appearing on the annual MDA ... Sunday, Aug. 31, 9/8c on ABC television stations across ... champion and current host of “All In, with Laila ... Fall Out Boy during the Muscular Dystrophy Association's nationally ...
(Date:8/29/2014)... According to a CNN article, entitled Medical ... new study found that those states who legalized medical ... decrease in the number of painkiller overdoses seen. By ... and comparing various states with and without legalized medical ... about a 25% decrease in painkiller prescription overdoses in ...
Breaking Medicine News(10 mins):Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2Health News:Champion Boxers Fight Back Against Muscle Disease 2Health News:Champion Boxers Fight Back Against Muscle Disease 3Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3
... Publications LLC today,announced that its highly anticipated book ... will be released on April 28, 2008 in ... online book retailers,including Amazon.com., *(PHOTO 72dpi: ... Creating Your Dream Life.) An entirely new ...
... by 55 percent from baseline ,severe, to moderately ... by 53 percent and increased patients, mobility almost three-fold, ... million Americans,suffer from osteoarthritis, with half a million Americans ... to be published in the April 2008,edition (Volume 22, ...
... PARK, Ill., April 16 Abbott (NYSE:,ABT) announced ... Japanese,Ministry of Health, Labour and Welfare for HUMIRA(R) ... with inadequate response to,conventional therapy. This approval is ... and will co-market HUMIRA with Eisai Co., Ltd. ...
... First in Nation to Embrace the Vending Industry,s ... ... The nation,s vending industry will,unveil tomorrow a new nationwide ... Association (NAMA),President Richard M. Geerdes, NCE announced today. The new ...
... researchers have identified a gene that is necessary in ... because expression of this gene is frequently suppressed in ... Charles Lopez, M.D., Ph.D., OHSU Cancer Institute (hematology/medical oncology), ... at a minisymposium on Wednesday April 16 at 10:30 ...
... Industry supports hundreds of programs helping millions in ... WASHINGTON, April 16 The worldwide,pharmaceutical industry ... research-based biopharmaceutical companies, global,health leaders and policymakers together ... the developing world., Serving as a convening ...
Cached Medicine News:Health News:21 Days to Creating Your Dream Life Will be Unleashed on April 28, 2008 2Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 2Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 3Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 4Health News:Study Shows Pine Bark Naturally Reduces Osteoarthritis 5Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 2Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 3Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 4Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 5Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 6Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 7Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 2Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 3Health News:Nation's Vending Industry Unveils New Health Oriented Vending Program: 4Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 3
(Date:8/29/2014)... , Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... blood instrumentation and consumables to the medical, research and ... Chairman and Chief Executive Officer, will present at the ... 2014 on Tuesday, September 9, 2014 at 12:30 p.m. ... Berkshire Place Hotel in New York City ...
(Date:8/29/2014)... , August 29, 2014 ... and collaboration software has announced a major new deal ... founded by renowned pathology expert, Dr. Marius Nap ... of the 26th European Congress of Pathology which is ... the ExCeL Arena, London where ...
(Date:8/29/2014)... , Aug. 29, 2014 ... PHG AEX: PHIA) ... European Society of Cardiology (ESC) Congress ... highlighting the full range of its cardiology solutions serving clinicians ... from prevention and diagnosis, to ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... Global pharmaceutical outsourcing has become increasingly prevalent, ... environment that has pharmaceutical and life sciences executives on ... PwC US and published today by Axendia, Inc., a ... 50 percent of pharmaceutical and life sciences executives surveyed ...
... NEWTOWN, Pa., Oct. 27 Essential Pharmaceuticals, LLC, ... and solutions to the life sciences market, announced ... distribution of three distinct animal-component-free products: serum replacement, ... the LiforCell® name: Cell-Ess™ ...
Cached Medicine Technology:As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 2As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 3As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 4As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed 5Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical 2
Stainless steel lancet blade in stainless steel....
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
AXIOM Multistar is a ceiling-mounted single plane C-Arm system for universal angiography, diagnostics and intervention...
... supports the cardiac workflow through Xper: a ... personalized user settings. In addition Xper integrates ... user interface. For example the interventional tools ... controlled from tableside.,The excellent image quality and ...
Medicine Products: